T82.828S Fibrosis due to vascular prosthetic devices, implants and grafts, sequela

Name of the Condition

Fibrosis due to vascular prosthetic devices, implants and grafts, sequela

Summary

Fibrosis due to vascular prosthetic devices, implants, and grafts, sequela, refers to the residual or chronic scar tissue formation around vascular devices that persists after the acute phase of the condition. This sequela may affect device function, surrounding tissues, or vascular health, requiring ongoing clinical evaluation and management.

Causes

Fibrosis in this context is primarily triggered by the body's response to foreign materials, such as vascular prosthetic devices, implants, and grafts. This reaction leads to scar tissue (fibrosis) formation around the device, which may become chronic and impact device integration or function over time.

Risk Factors

• Previous vascular device implantation or graft placement
• History of surgeries involving implants or grafts
• Underlying chronic inflammatory conditions
• Prolonged device use or repeated interventions

Symptoms

• Persistent pain or tenderness around the site of the implant
• Swelling or skin changes over the affected area
• Reduced effectiveness of the vascular prosthetic device
• Possible changes in blood flow or vascular function

Diagnosis

Diagnosis involves clinical assessment, imaging (e.g., ultrasound, MRI, or CT) to visualize fibrosis and device integrity, and laboratory tests to evaluate vascular function or signs of inflammation. Documentation should specify the nature of the fibrosis and its impact on the device or vascular system.

Treatment Options

• Anti-inflammatory medications to reduce chronic inflammation and pain
• Surgical intervention to address fibrosis or device malfunction
• Monitoring of device function and vascular health
• Physical therapy or rehabilitation to manage symptoms

Prognosis and Follow-Up

Prognosis depends on the extent of fibrosis, device function, and underlying vascular health. Regular follow-up is essential to monitor for complications, assess device integrity, and adjust treatment as needed. Long-term management may be required to maintain vascular function.

Complications

• Device malfunction or failure
• Reduced blood flow or vascular obstruction
• Chronic pain or discomfort
• Increased risk of infection or further tissue damage

Lifestyle & Prevention

• Maintain regular follow-up appointments with healthcare providers
• Report any new or worsening symptoms promptly
• Follow post-procedural care instructions for implanted devices
• Manage underlying conditions that may exacerbate inflammation

When to Seek Professional Help

Seek medical attention if you experience persistent pain, swelling, changes in device function, or signs of infection (e.g., redness, fever). Prompt evaluation is important to prevent complications and ensure appropriate management.

Tips for Medical Coders

Document the specific nature of the fibrosis, its impact on the vascular prosthetic device, and any sequela-related complications. Ensure the code T82.828S is used for chronic or residual fibrosis due to vascular prosthetic devices, implants, or grafts, and that the "sequela" designation is appropriately applied based on clinical documentation.